You can take a free assessment to see if you are a candidate for our personalized weight loss programs
Gaining Weight on Ozempic: Causes, Solutions and When to See Your GP Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes management, typically associated with weight loss
For example, the dosage should not exceed 600 units within a 90-day period
Clinical evidence suggests that extended use of GLP-1 medications is safe and effective, with patients maintaining weight loss for years when they remain on treatment
DOI.org (Crossref) , Chedid, V., et al
In some cases, however, ISRs can be more severe, and may require medical attention